Xia et al conducted an immunohistochemical analysis for EGFR on 221 primary ovarian carcinomas of mixed grades, and he reported a 28.3% nuclear positivity among his cohort, and showed that nuclear expression correlated with low survival rates. This evidence concerns the gene EGFR and ovarian carcinoma.